Fowler A - Search Results

1

The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV₁/FVC Ratio in Tiotropium Safety and Performance in Respimat Participants.

Calverley PMA, Mueller A, Fowler A, Metzdorf N, Wise RA. Calverley PMA, et al. Among authors: fowler a. Ann Am Thorac Soc. 2018 Feb;15(2):200-208. doi: 10.1513/AnnalsATS.201703-194OC. Ann Am Thorac Soc. 2018. PMID: 28957643 Clinical Trial.

2

Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.

Wise R, Calverley PM, Dahl R, Dusser D, Metzdorf N, Müller A, Fowler A, Anzueto A. Wise R, et al. Among authors: fowler a. NPJ Prim Care Respir Med. 2015 Nov 5;25:15067. doi: 10.1038/npjpcrm.2015.67. NPJ Prim Care Respir Med. 2015. PMID: 26540491 Free PMC article. Clinical Trial.

3

Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial.

Dahl R, Calverley PM, Anzueto A, Metzdorf N, Fowler A, Mueller A, Wise R, Dusser D. Dahl R, et al. Among authors: fowler a. BMJ Open. 2015 Dec 29;5(12):e009015. doi: 10.1136/bmjopen-2015-009015. BMJ Open. 2015. PMID: 26715479 Free PMC article. Clinical Trial.

4

Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial.

Dusser D, Wise RA, Dahl R, Anzueto A, Carter K, Fowler A, Calverley PM. Dusser D, et al. Among authors: fowler a. Int J Chron Obstruct Pulmon Dis. 2016 Jan 20;11:133-45. doi: 10.2147/COPD.S97924. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 26855568 Free PMC article. Clinical Trial.

5

Discordance in investigator-reported and adjudicated sudden death in TIOSPIR.

Wise RA, Kowey PR, Austen G, Mueller A, Metzdorf N, Fowler A, McGarvey LP. Wise RA, et al. Among authors: fowler a. ERJ Open Res. 2017 Mar 20;3(1):00073-2016. doi: 10.1183/23120541.00073-2016. eCollection 2017 Jan. ERJ Open Res. 2017. PMID: 28344980 Free PMC article.

6

FEV₁ recovery following methacholine challenge in asthma: Variability and comparison of methods.

Singh D, Khan N, Dean J, Fowler A, Gupta A, Endriss V, Iacono P, Disse B. Singh D, et al. Among authors: fowler a. Pulm Pharmacol Ther. 2020 Feb;60:101876. doi: 10.1016/j.pupt.2019.101876. Epub 2019 Dec 13. Pulm Pharmacol Ther. 2020. PMID: 31843704 Free article. Clinical Trial.

7

Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.

Hall IP, Fowler AV, Gupta A, Tetzlaff K, Nivens MC, Sarno M, Finnigan HA, Bateman ED, Rand Sutherland E. Hall IP, et al. Among authors: fowler av. Pulm Pharmacol Ther. 2015 Jun;32:37-44. doi: 10.1016/j.pupt.2015.03.003. Epub 2015 Apr 8. Pulm Pharmacol Ther. 2015. PMID: 25861737 Free article. Clinical Trial.

8

A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.

Kerwin E, Pascoe S, Bailes Z, Nathan R, Bernstein D, Dahl R, von Maltzahn R, Robbins K, Fowler A, Lee L. Kerwin E, et al. Among authors: fowler a. Respir Res. 2020 Jun 12;21(1):148. doi: 10.1186/s12931-020-01400-5. Respir Res. 2020. PMID: 32532275 Free PMC article. Clinical Trial.

9

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma.

Fowler A, Koenen R, Hilbert J, Blatchford J, Kappeler D, Benediktus E, Wood C, Gupta A. Fowler A, et al. J Clin Pharmacol. 2017 Nov;57(11):1444-1453. doi: 10.1002/jcph.947. Epub 2017 Jun 13. J Clin Pharmacol. 2017. PMID: 28609567 Clinical Trial.

10

Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study.

Nakamura Y, Hozawa S, Sagara H, Ohbayashi H, Lee LA, Crawford J, Tamaoki J, Nishi T, Fowler A. Nakamura Y, et al. Among authors: fowler a. Curr Med Res Opin. 2021 Sep;37(9):1657-1665. doi: 10.1080/03007995.2021.1944849. Epub 2021 Jul 14. Curr Med Res Opin. 2021. PMID: 34162298 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,201 results

Search Page